Hm Payson & CO Azenta, Inc. Transaction History

Hm Payson & CO

$6.76 Billion
Q3 2025

A detailed history of Hm Payson & CO transactions in Azenta, Inc. stock. As of the latest transaction made, Hm Payson & CO holds 17,357 shares of AZTA stock, worth $516,370. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,357

Previous 18,917 8.25%

Holding current value

$516,370

Previous $655,000 23.97%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 17, 2025	SELL	$26.9 - $34.48 $41,964 - $53,788	-1,560 Reduced 8.25%	17,357 $498,000
Q1 2025 Apr 29, 2025	SELL	$34.61 - $54.75 $32,879 - $52,012	-950 Reduced 4.78%	18,917 $655,000
Q3 2024 Oct 28, 2024	SELL	$45.84 - $62.29 $476,736 - $647,816	-10,400 Reduced 34.36%	19,867 $962,000
Q1 2024 Jun 20, 2024	SELL	$57.82 - $67.51 $180,918 - $211,238	-3,129 Reduced 9.37%	30,267 $1.82 Million
Q4 2023 Feb 13, 2024	BUY	$44.02 - $66.3 $374,170 - $563,550	8,500 Added 34.14%	33,396 $2.18 Million

Q3 2023 Nov 06, 2023	SELL	$44.08 - $57.76 $179,581 - $235,314	-4,074 Reduced 14.06%	24,896 $1.25 Million
Q4 2022 Feb 06, 2023	BUY	$38.6 - $62.07 $835,497 - $1.34 Million	21,645 Added 295.49%	28,970 $1.69 Million
Q1 2022 May 12, 2022	BUY	$76.3 - $103.81 $114,450 - $155,715	1,500 Added 25.75%	7,325 $607,000
Q3 2021 Nov 30, 2021	BUY	$77.49 - $109.17 $141,419 - $199,235	1,825 Added 45.63%	5,825 $596,000
Q1 2021 Jun 15, 2021	SELL	$66.32 - $90.93 $66,320 - $90,930	-1,000 Reduced 20.0%	4,000 $327,000
Q4 2020 Mar 10, 2021	BUY	$46.7 - $75.22 $233,500 - $376,100	5,000 New	5,000 $339,000

Others Institutions Holding AZTA

# of Institutions

311

Shares Held

49.4M

Call Options Held

79.2K

Put Options Held

83.5K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $2.23B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account